%0 Journal Article
%T Restoring Efficacy to Cotrimoxazole, against Resistant <i>Salmonella pullorum, </i> with <i>Medicinal Synthetic Aluminum-Magnesium Silicate <sup>®</sup></i> [MSAMS: Al<sub>4</sub> (SiO<sub>4</sub>)<sub>3</sub> + 3Mg<sub>2</sub>SiO<sub>4</sub> ¡ú 2Al<sub>2</sub> Mg<sub>3</sub> (SiO<sub>4</sub>)<sub>3</sub>]
%A Maduike Chiehiura Onwubiko Ezeibe
%A Aniefiok Emerson Udom
%A Obiageri Favour Onyeachonam
%A Ijeoma Joy Ogbonna
%J Health
%P 1162-1168
%@ 1949-5005
%D 2019
%I Scientific Research Publishing
%R 10.4236/health.2019.119090
%X To restore efficacy (¡Ý95% infection-reduction) to drugs against resistant infections (now, posing a bigger medical challenge, globally, than even HIV/AIDS), Cotrimoxazole was formulated with a synthetic Aluminum-magnesium silicate (Medicinal mineral which molecules are made of Nanoparticles, that is already in use as pharmaceutical-stabilizing agent) and used with antioxidants to treat Cotrimoxazole-resistant Salmonella pulorum infected chicks. Chick-groups A, B and C were fed antioxidants-fortified feed while groups D, E, F, G and H were not. The treatment-groups and their Cotrimoxazole doses/formulations were: A and D (100%/MSAMS-Cotrimoxazole); B and E (75%/MSAMS-Cotrimoxazole); C and F (50%/MSAMS-Cotrimoxazole) and G (100%/Cotrimoxazole). Infection-reductions (96.23% and 94.98%) of the groups of 75%/MSAMS-Cotrimoxazole/antioxidants and 75%/MSAMS-Cotrimoxazole were significantly (P ¡Ü 0.05) better than 76.99% (100%/Cotrimoxazole); 10.04% (50%/MSAMS-Cotrimoxazole/antioxidants); 1.60% (50%/MSAMS-Cotrimoxazole); −212.60% (100%/MSAMS-Cotrimoxazole/antioxidants) and −230.96% (100%/MSAMS-Cotrimoxazole).
%K Cure for Resistant Infections
%K Salmonellosis
%K MSAMS
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=95424